[Chronic interstitial lung disease in children: Diagnostic approach and management]

Area of Science:

• Pediatric Pulmonology
• Rare Diseases
• Interstitial Lung Disease

Background:

• Chronic interstitial lung disease (ILD) in children is a rare, heterogeneous group of disorders.
• It involves inflammation of the alveolar wall and interstitium, leading to impaired gas exchange.
• Clinical presentation varies significantly with age, from neonatal respiratory distress to insidious onset in older children.

Purpose of the Study:

• To outline the diagnostic and therapeutic strategies for pediatric interstitial lung disease.
• To emphasize the age-dependent clinical manifestations and diagnostic challenges.
• To review current treatment modalities and supportive care for children with ILD.

Main Methods:

• Diagnosis relies on a combination of noninvasive methods including clinical history, pulmonary function tests, chest X-ray, and high-resolution CT scans.
• Invasive techniques such as bronchoalveolar lavage and various biopsy methods are employed for etiological identification.
• Assessment considers the impact of the disease and aims to identify the underlying cause.

Main Results:

• Diagnostic approach involves recognition, impact assessment, and etiological identification.
• Age influences symptom onset and presentation, impacting diagnostic timelines.
• Treatment strategies are tailored to the specific pathology, often involving corticosteroids and immunosuppressants.

Conclusions:

• Pediatric ILD diagnosis requires a systematic approach integrating noninvasive and invasive methods.
• Management necessitates individualized treatment plans, including anti-inflammatory agents, supportive care, and consideration of lung transplantation for severe cases.
• Early recognition and appropriate intervention are crucial for managing this rare group of pediatric lung disorders.